Although advances in hematology have led the way in many fields of basic and translational biomedical research, hematologic diseases remain major threats to public health. The Molecular Hematology training program provides critical support for predoctoral and postdoctoral trainees, including MD and MD/PhD trainees who have completed the clinical training component of the Hematology-Oncology fellowship program. Trainees receive intensive mentoring and career counseling, and participate in coursework, journal clubs, and seminars.

Key Areas of Training

Research topics available to trainees reflect the multidisciplinary expertise of the participating mentors and include:

  • Pathogenesis of hemorrhagic and thrombotic disorders
  • Regulation of blood coagulation and fibrinolysis
  • Mechanisms of hematopoiesis
  • Telomerase defects in bone marrow failure syndromes
  • Molecular basis for protein trafficking in mammalian cells
  • Pathogenesis of leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, and congenital neutropenia

Completion of this program prepares talented trainees for careers in basic and translational hematology research, to make discoveries that will transform the diagnosis and treatment of hematologic diseases.

For more information

Please contact T32 Training Coordinator Michael Sullivan ( or T32 Program Director Stephen Oh, MD, PhD (